S
Simon Tiberi
Researcher at Queen Mary University of London
Publications - 146
Citations - 7669
Simon Tiberi is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Tuberculosis & Bedaquiline. The author has an hindex of 33, co-authored 145 publications receiving 4089 citations. Previous affiliations of Simon Tiberi include Imperial College Healthcare & Royal London Hospital.
Papers
More filters
Journal ArticleDOI
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.
John Allotey,Elena Stallings,Mercedes Bonet,Magnus Yap,Shaunak Chatterjee,Tania Kew,Luke Debenham,Anna Clavé Llavall,A. Dixit,D. Zhou,Rishab Balaji,Siang Ing Lee,X. Qiu,M. Yuan,Dyuti Coomar,Madelon van Wely,Elizabeth van Leeuwen,Elena Kostova,Heinke Kunst,Asma Khalil,Simon Tiberi,Vanessa Brizuela,Nathalie Broutet,Edna Kara,Caron Kim,Anna Thorson,Olufemi T Oladapo,Lynne M. Mofenson,Javier Zamora,Shakila Thangaratinam +29 more
TL;DR: Pregnant and recently pregnant women are less likely to manifest covid-19 related symptoms of fever and myalgia than non-pregnant women of reproductive age, and high intensive care women without high risk of disease are potentially more likely to be risk factors for covid19 Pre-existing comorbidity.
Journal ArticleDOI
Clinical Manifestations, Risk Factors, and Maternal and Perinatal Outcomes of Coronavirus Disease 2019 in Pregnancy: Living Systematic Review and Meta-analysis
John Allotey,Elena Stallings,Mercedes Bonet,Magnus Yap,Shaunak Chatterjee,Tania Kew,Luke Debenham,Anna Clavé Llavall,A. Dixit,D. Zhou,Rishab Balaji,Siang Ing Lee,X. Qiu,M. Yuan,Dyuti Coomar,M. van Wely,E. van Leeuwen,Elena Kostova,Heinke Kunst,Asma Khalil,Simon Tiberi,Vanessa Brizuela,Nathalie Broutet,Edna Kara,Caron Kim,Anna Thorson,Olufemi T Oladapo,Lynne M. Mofenson,Javier Zamora,Shakila Thangaratinam +29 more
Journal ArticleDOI
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad,Shama D. Ahuja,Onno W. Akkerman,Jan-Willem C. Alffenaar,Laura F Anderson,Parvaneh Baghaei,Didi Bang,Pennan M. Barry,Mayara Lisboa Bastos,Digamber Behera,Andrea Benedetti,Gregory P. Bisson,Martin J. Boeree,Maryline Bonnet,Sarah K. Brode,James C.M. Brust,Ying Cai,Eric Caumes,J. Peter Cegielski,Rosella Centis,Pei-Chun Chan,Edward D. Chan,Kwok-Chiu Chang,Macarthur Charles,Andra Cirule,Margareth Pretti Dalcolmo,Lia D'Ambrosio,Gerard de Vries,Keertan Dheda,Aliasgar Esmail,Jennifer Flood,Gregory J. Fox,Mathilde Fréchet-Jachym,Geisa Fregona,Regina Gayoso,Medea Gegia,Maria Tarcela Gler,Sue Gu,Lorenzo Guglielmetti,Timothy H. Holtz,Jennifer Hughes,Petros Isaakidis,Leah G. Jarlsberg,Russell R. Kempker,Salmaan Keshavjee,Faiz Ahmad Khan,Maia Kipiani,Serena P. Koenig,Won-Jung Koh,Afranio Lineu Kritski,Liga Kuksa,Charlotte Kvasnovsky,Nakwon Kwak,Zhiyi Lan,Christoph Lange,Rafael Laniado-Laborín,Myungsun Lee,Vaira Leimane,Chi-Chiu Leung,Eric Chung Ching Leung,Pei Zhi Li,Phil Lowenthal,Ethel Leonor Noia Maciel,Suzanne M. Marks,Sundari Mase,Lawrence Mbuagbaw,Giovanni Battista Migliori,Vladimir Milanov,Ann C. Miller,Carole D. Mitnick,Chawangwa Modongo,Erika Mohr,Ignacio Monedero,Payam Nahid,Norbert Ndjeka,Max R. O'Donnell,Nesri Padayatchi,Domingo Palmero,Jean W. Pape,Laura Jean Podewils,Ian R Reynolds,Vija Riekstina,Jérôme Robert,Maria I. Rodriguez,Barbara Seaworth,Kwonjune J. Seung,Kathryn Schnippel,Tae Sun Shim,Rupak Singla,Sarah Smith,Giovanni Sotgiu,Ganzaya Sukhbaatar,Payam Tabarsi,Simon Tiberi,Anete Trajman,Lisa Trieu,Zarir F Udwadia,Tjip S. van der Werf,Nicolas Veziris,Piret Viiklepp,Stalz Charles Vilbrun,Kathleen F. Walsh,Janice Westenhouse,Wing Wai Yew,Jae-Joon Yim,Nicola M. Zetola,Matteo Zignol,Dick Menzies +107 more
TL;DR: Treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis, and the need for trials to ascertain the optimal combination and duration of these drugs is emphasised.
Journal ArticleDOI
Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
Jeremiah Chakaya,Jeremiah Chakaya,Mishal S Khan,Francine Ntoumi,Eleni Aklillu,Razia Fatima,Peter Mwaba,Nathan Kapata,Sayoki Mfinanga,Sayoki Mfinanga,Seyed E. Hasnain,Patrick D. M. C. Katoto,André N.H. Bulabula,Nadia A. Sam-Agudu,Nadia A. Sam-Agudu,Jean B. Nachega,Jean B. Nachega,Jean B. Nachega,Simon Tiberi,Simon Tiberi,Timothy D. McHugh,Ibrahim Abubakar,Alimuddin Zumla +22 more
TL;DR: In 2019, TB remained the most common cause of death from a single infectious pathogen globally, and an estimated 10.0 million people developed TB disease in 2019, and there were an estimated 1.2 million TB deaths among HIV-negative people and an additional 208, 000 deaths among people living with HIV as discussed by the authors.
Journal ArticleDOI
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Marina Tadolini,Luigi Codecasa,José-María García-García,François-Xavier Blanc,Sergey Borisov,Jan-Willem C. Alffenaar,Jan-Willem C. Alffenaar,Claire Andrejak,Pierre Bachez,Pierre-Alexandre Bart,Evgeny Belilovski,José Cardoso-Landivar,Rosella Centis,Lia D'Ambrosio,Maria Luiza de Souza-Galvão,Ángel Domínguez-Castellano,Samir Dourmane,Mathilde Fréchet Jachym,Antoine Froissart,Vania Giacomet,Delia Goletti,Soazic Grard,Gina Gualano,Armine Izadifar,Damien Le Dû,Margarita Marín Royo,Jesica Mazza-Stalder,Ilaria Motta,Catherine W.M. Ong,Fabrizio Palmieri,Frédéric Rivière,Teresa Rodrigo,Denise Rossato Silva,Adrián Sánchez-Montalvá,Matteo Saporiti,Paolo Scarpellini,Frédéric Schlemmer,Antonio Spanevello,Elena Sumarokova,Eva Tabernero,Paul A. Tambyah,Simon Tiberi,Simon Tiberi,Alessandro Torre,Dina Visca,Miguel Zabaleta Murguiondo,Giovanni Sotgiu,Giovanni Battista Migliori +47 more
TL;DR: Diagnostic, treatment and outcome details of 49 COVID-19 patients with concurrent or previous tuberculosis from 8 countries show varied clinical profiles.